CapsoVision

CapsoVision EBITDA Growth YoY

The Year-over-Year EBITDA Growth of CapsoVision (CV) as of Oct 18, 2026 is -28.11 %. In the previous year, Year-over-Year EBITDA Growth was -75.53 % — a change of -62.78% (higher).

EBITDA Growth YoY

-28.11 %

YoY

-62.78%

Last updated:

Year-over-Year EBITDA Growth of CapsoVision is 2025 -28.11 % . Year-over-Year EBITDA Growth of CapsoVision was 2024 -75.53 % . It decreases by -62.78% higher compared to the previous year.

The CapsoVision EBITDA Growth YoY history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA Growth YoY
Date
EBITDA Growth YoY
Jan 1, 2024
-75.53 USD
Jan 1, 2025
-28.11 USD
The CapsoVision EBITDA Growth YoY history
YEAREBITDA Growth YoYYoY
-28.11 %-62.78%
-75.53 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

CapsoVision Stock analysis

What does CapsoVision do? CapsoVision Inc is a health care company based in Saratoga, California, operating within the health care sector. The company has 99 employees and is scheduled to go public with an IPO on July 2, 2025. CapsoVision develops medical technology products, including a small bowel capsule endoscope called CapsoCam Plus. This device utilizes a 360 panoramic lateral view to provide more comprehensive imaging compared to traditional end-facing cameras. The product is designed to be wire-free, enhancing patient comfort and convenience. The company also offers CapsoCloud, a cloud-based software application for secure and convenient clinical data management. Additionally, CapsoVision provides a capsule collection kit, a single-use, sanitary kit for patients to collect, store, and transport the CapsoCam Plus capsule. The company's website is https://www.capsovision.com/. CapsoVision Inc is focused on advancing medical technology solutions for gastrointestinal diagnostics, with a particular emphasis on improving patient experience through innovative design and secure data handling. CapsoVision is one of the most popular companies on Eulerpool.

Frequently Asked Questions about CapsoVision stock

Year-over-Year EBITDA Growth of CapsoVision is -28.11 % in 2025.

On Eulerpool you can find the complete historical development of Year-over-Year EBITDA Growth CapsoVision since 2006 – with annual values, charts, and detailed analysis.

EBITDA growth measures the percentage change in EBITDA compared to the prior year. It shows changes in operating cash earnings before capital structure effects.

To evaluate Year-over-Year EBITDA Growth's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Year-over-Year EBITDA Growth.

Year-over-Year EBITDA Growth's is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Year-over-Year EBITDA Growth's CapsoVision historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Growth — CapsoVision

All Key Metrics — CapsoVision